Use of Interrupted Time Series Analysis in Evaluating Health Care Quality Improvements
Interrupted time series (ITS) analysis is arguably the strongest quasi-experimental research design. ITS is particularly useful when a randomized trial is infeasible or unethical. The approach usually involves constructing a time series of population-level rates for a particular quality improvement...
Saved in:
| Published in | Academic pediatrics Vol. 13; no. 6; pp. S38 - S44 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.11.2013
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Interrupted time series (ITS) analysis is arguably the strongest quasi-experimental research design. ITS is particularly useful when a randomized trial is infeasible or unethical. The approach usually involves constructing a time series of population-level rates for a particular quality improvement focus (eg, rates of attention-deficit/hyperactivity disorder [ADHD] medication initiation) and testing statistically for a change in the outcome rate in the time periods before and time periods after implementation of a policy/program designed to change the outcome. In parallel, investigators often analyze rates of negative outcomes that might be (unintentionally) affected by the policy/program. We discuss why ITS is a useful tool for quality improvement. Strengths of ITS include the ability to control for secular trends in the data (unlike a 2-period before-and-after t test), ability to evaluate outcomes using population-level data, clear graphical presentation of results, ease of conducting stratified analyses, and ability to evaluate both intended and unintended consequences of interventions. Limitations of ITS include the need for a minimum of 8 time periods before and 8 after an intervention to evaluate changes statistically, difficulty in analyzing the independent impact of separate components of a program that are implemented close together in time, and existence of a suitable control population. Investigators must also be careful not to make individual-level inferences when population-level rates are used to evaluate interventions (though ITS can be used with individual-level data). A brief description of ITS is provided, including a fully implemented (but hypothetical) study of the impact of a program to reduce ADHD medication initiation in children younger than 5 years old and insured by Medicaid in Washington State. An example of the database needed to conduct an ITS is provided, as well as SAS code to implement a difference-in-differences model using preschool-age children in California as a comparison group. |
|---|---|
| AbstractList | Interrupted time series (ITS) analysis is arguably the strongest quasi-experimental research design. ITS is particularly useful when a randomized trial is infeasible or unethical. The approach usually involves constructing a time series of population-level rates for a particular quality improvement focus (eg, rates of attention-deficit/hyperactivity disorder [ADHD] medication initiation) and testing statistically for a change in the outcome rate in the time periods before and time periods after implementation of a policy/program designed to change the outcome. In parallel, investigators often analyze rates of negative outcomes that might be (unintentionally) affected by the policy/program. We discuss why ITS is a useful tool for quality improvement. Strengths of ITS include the ability to control for secular trends in the data (unlike a 2-period before-and-after t test), ability to evaluate outcomes using population-level data, clear graphical presentation of results, ease of conducting stratified analyses, and ability to evaluate both intended and unintended consequences of interventions. Limitations of ITS include the need for a minimum of 8 time periods before and 8 after an intervention to evaluate changes statistically, difficulty in analyzing the independent impact of separate components of a program that are implemented close together in time, and existence of a suitable control population. Investigators must also be careful not to make individual-level inferences when population-level rates are used to evaluate interventions (though ITS can be used with individual-level data). A brief description of ITS is provided, including a fully implemented (but hypothetical) study of the impact of a program to reduce ADHD medication initiation in children younger than 5 years old and insured by Medicaid in Washington State. An example of the database needed to conduct an ITS is provided, as well as SAS code to implement a difference-in-differences model using preschool-age children in California as a comparison group. Abstract Interrupted time series (ITS) analysis is arguably the strongest quasi-experimental research design. ITS is particularly useful when a randomized trial is infeasible or unethical. The approach usually involves constructing a time series of population-level rates for a particular quality improvement focus (eg, rates of attention-deficit/hyperactivity disorder [ADHD] medication initiation) and testing statistically for a change in the outcome rate in the time periods before and time periods after implementation of a policy/program designed to change the outcome. In parallel, investigators often analyze rates of negative outcomes that might be (unintentionally) affected by the policy/program. We discuss why ITS is a useful tool for quality improvement. Strengths of ITS include the ability to control for secular trends in the data (unlike a 2-period before-and-after t test), ability to evaluate outcomes using population-level data, clear graphical presentation of results, ease of conducting stratified analyses, and ability to evaluate both intended and unintended consequences of interventions. Limitations of ITS include the need for a minimum of 8 time periods before and 8 after an intervention to evaluate changes statistically, difficulty in analyzing the independent impact of separate components of a program that are implemented close together in time, and existence of a suitable control population. Investigators must also be careful not to make individual-level inferences when population-level rates are used to evaluate interventions (though ITS can be used with individual-level data). A brief description of ITS is provided, including a fully implemented (but hypothetical) study of the impact of a program to reduce ADHD medication initiation in children younger than 5 years old and insured by Medicaid in Washington State. An example of the database needed to conduct an ITS is provided, as well as SAS code to implement a difference-in-differences model using preschool-age children in California as a comparison group. Interrupted time series (ITS) analysis is arguably the strongest quasi-experimental research design. ITS is particularly useful when a randomized trial is infeasible or unethical. The approach usually involves constructing a time series of population-level rates for a particular quality improvement focus (eg, rates of attention-deficit/hyperactivity disorder [ADHD] medication initiation) and testing statistically for a change in the outcome rate in the time periods before and time periods after implementation of a policy/program designed to change the outcome. In parallel, investigators often analyze rates of negative outcomes that might be (unintentionally) affected by the policy/program. We discuss why ITS is a useful tool for quality improvement. Strengths of ITS include the ability to control for secular trends in the data (unlike a 2-period before-and-after t test), ability to evaluate outcomes using population-level data, clear graphical presentation of results, ease of conducting stratified analyses, and ability to evaluate both intended and unintended consequences of interventions. Limitations of ITS include the need for a minimum of 8 time periods before and 8 after an intervention to evaluate changes statistically, difficulty in analyzing the independent impact of separate components of a program that are implemented close together in time, and existence of a suitable control population. Investigators must also be careful not to make individual-level inferences when population-level rates are used to evaluate interventions (though ITS can be used with individual-level data). A brief description of ITS is provided, including a fully implemented (but hypothetical) study of the impact of a program to reduce ADHD medication initiation in children younger than 5 years old and insured by Medicaid in Washington State. An example of the database needed to conduct an ITS is provided, as well as SAS code to implement a difference-in-differences model using preschool-age children in California as a comparison group.Interrupted time series (ITS) analysis is arguably the strongest quasi-experimental research design. ITS is particularly useful when a randomized trial is infeasible or unethical. The approach usually involves constructing a time series of population-level rates for a particular quality improvement focus (eg, rates of attention-deficit/hyperactivity disorder [ADHD] medication initiation) and testing statistically for a change in the outcome rate in the time periods before and time periods after implementation of a policy/program designed to change the outcome. In parallel, investigators often analyze rates of negative outcomes that might be (unintentionally) affected by the policy/program. We discuss why ITS is a useful tool for quality improvement. Strengths of ITS include the ability to control for secular trends in the data (unlike a 2-period before-and-after t test), ability to evaluate outcomes using population-level data, clear graphical presentation of results, ease of conducting stratified analyses, and ability to evaluate both intended and unintended consequences of interventions. Limitations of ITS include the need for a minimum of 8 time periods before and 8 after an intervention to evaluate changes statistically, difficulty in analyzing the independent impact of separate components of a program that are implemented close together in time, and existence of a suitable control population. Investigators must also be careful not to make individual-level inferences when population-level rates are used to evaluate interventions (though ITS can be used with individual-level data). A brief description of ITS is provided, including a fully implemented (but hypothetical) study of the impact of a program to reduce ADHD medication initiation in children younger than 5 years old and insured by Medicaid in Washington State. An example of the database needed to conduct an ITS is provided, as well as SAS code to implement a difference-in-differences model using preschool-age children in California as a comparison group. |
| Author | Penfold, Robert B. Zhang, Fang |
| Author_xml | – sequence: 1 givenname: Robert B. surname: Penfold fullname: Penfold, Robert B. email: Penfold.r@ghc.org organization: Group Health Research Institute and the Department of Health Services Research, University of Washington, Seattle, Wash – sequence: 2 givenname: Fang surname: Zhang fullname: Zhang, Fang organization: Harvard Pilgrim Healthcare Research Institute and Department of Population Medicine, Harvard University, Boston, Mass |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24268083$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk1r3DAQhkVIyVfzB3IoOvayjiTbWm0phbCkzUKglCS9irE8brWV5a0kL-y_j8wmOQSanqTD-8wwz8wpOfSDR0IuOCs44_JyXYCBTSEYLwumCsbEATnhai5nQsn54cu_XhyT0xjXjMlSKXlEjkUlpGKqPCE_HyLSoaMrnzCEcZOwpfe2R3qHwWKkVx7cLtpIrafXW3AjJOt_0RsEl37TJQSkP0ZwNu3oqt-EYYs9-hTfk3cduIjnT-8Zefh6fb-8md1-_7ZaXt3OTC1UmnHTyK5hi7LtWIMGmhqqVjHWgZizuakRq7ItAeQC2q7KcxqoBZiOLaqyrgSWZ-Tjvm5u_XfEmHRvo0HnwOMwRs0rWef5uZI5-uEpOjY9tnoTbA9hp59d5IDaB0wYYgzYaWNTHnfwKYB1mjM9addrPWnXk3bNlM7aMypeoc_V34Q-7yHMgrYWg47GojfY2oAm6Xawb-NfXuHGWW8NuD-4w7gexpB3lxXoKDTTd9MxTLfAy0xzNgn59O8C_-v-CMVmxCU |
| CitedBy_id | crossref_primary_10_1111_jep_13266 crossref_primary_10_3389_frdem_2024_1404662 crossref_primary_10_1287_isre_2022_1159 crossref_primary_10_1093_jamia_ocx099 crossref_primary_10_1007_s11135_020_01087_2 crossref_primary_10_4103_IJAM_IJAM_120_20 crossref_primary_10_1097_PEC_0000000000001376 crossref_primary_10_1097_MPG_0000000000002054 crossref_primary_10_1186_s12882_021_02491_y crossref_primary_10_1080_25741292_2019_1610147 crossref_primary_10_2196_40913 crossref_primary_10_1186_s12913_019_4821_7 crossref_primary_10_1586_14737167_2016_1136790 crossref_primary_10_1016_j_sapharm_2022_06_008 crossref_primary_10_1007_s40264_017_0524_3 crossref_primary_10_1007_s00038_018_1091_9 crossref_primary_10_1007_s10742_021_00267_3 crossref_primary_10_1136_bmjopen_2017_021290 crossref_primary_10_1161_CIRCOUTCOMES_123_010078 crossref_primary_10_1111_1475_6773_13605 crossref_primary_10_1007_s10916_022_01832_0 crossref_primary_10_1164_rccm_201801_0118PP crossref_primary_10_1177_08874034241271175 crossref_primary_10_1016_j_ajic_2020_01_006 crossref_primary_10_1111_cdoe_12544 crossref_primary_10_1002_hsr2_284 crossref_primary_10_1542_peds_2015_1202 crossref_primary_10_1001_jamanetworkopen_2022_44086 crossref_primary_10_1007_s12310_023_09614_w crossref_primary_10_7861_futurehosp_5_3_198 crossref_primary_10_1007_s12630_022_02236_x crossref_primary_10_1016_j_resuscitation_2017_09_027 crossref_primary_10_1007_s40264_019_00840_3 crossref_primary_10_1016_j_afjem_2018_10_002 crossref_primary_10_1016_j_jadr_2022_100432 crossref_primary_10_1097_PEC_0000000000002484 crossref_primary_10_1016_j_geomorph_2018_01_004 crossref_primary_10_1177_07340168221139356 crossref_primary_10_1001_jamahealthforum_2024_3656 crossref_primary_10_1016_S1473_3099_19_30573_0 crossref_primary_10_1016_j_health_2023_100250 crossref_primary_10_1136_bmjoq_2023_002594 crossref_primary_10_30773_pi_2022_0179 crossref_primary_10_1136_bmjopen_2020_036758 crossref_primary_10_1016_j_acap_2019_04_010 crossref_primary_10_1111_1475_6773_12539 crossref_primary_10_1017_S1041610217002897 crossref_primary_10_1371_journal_pone_0278072 crossref_primary_10_1136_bmjinnov_2020_000420 crossref_primary_10_1002_acr_23848 crossref_primary_10_1016_j_xops_2025_100718 crossref_primary_10_1542_peds_2020_0272 crossref_primary_10_1136_bmjopen_2019_031208 crossref_primary_10_1097_MLR_0000000000001475 crossref_primary_10_1176_appi_ps_202100363 crossref_primary_10_1542_peds_2016_0378 crossref_primary_10_1007_s40259_023_00601_w crossref_primary_10_1097_MD_0000000000021796 crossref_primary_10_1038_s41591_024_02806_0 crossref_primary_10_1186_s12888_016_0880_z crossref_primary_10_1136_bmjopen_2021_059983 crossref_primary_10_1016_j_ijcard_2021_12_016 crossref_primary_10_1080_00952990_2022_2033758 crossref_primary_10_1093_occmed_kqz156 crossref_primary_10_1136_bmjopen_2016_015363 crossref_primary_10_1371_journal_pone_0210081 crossref_primary_10_1542_hpeds_2020_005603 crossref_primary_10_3389_fpubh_2023_1062753 crossref_primary_10_3390_antibiotics13090792 crossref_primary_10_1002_jcad_12508 crossref_primary_10_1017_ice_2020_1407 crossref_primary_10_1016_j_puhe_2015_07_032 crossref_primary_10_18553_jmcp_2018_24_7_700 crossref_primary_10_1001_jama_2021_11048 crossref_primary_10_1093_cid_ciy155 crossref_primary_10_1542_peds_2022_058820 crossref_primary_10_1016_j_iatssr_2023_05_001 crossref_primary_10_1080_02813432_2018_1426147 crossref_primary_10_1136_bmjopen_2021_053191 crossref_primary_10_1186_s12891_021_03959_6 crossref_primary_10_1186_s12913_023_10393_y crossref_primary_10_1016_j_jbi_2020_103567 crossref_primary_10_1186_s12884_016_1219_y crossref_primary_10_1186_s12961_021_00797_9 crossref_primary_10_1542_hpeds_2020_000380 crossref_primary_10_1111_apt_15209 crossref_primary_10_1001_jamanetworkopen_2023_22798 crossref_primary_10_1016_j_annemergmed_2016_06_026 crossref_primary_10_1093_pm_pnaa002 crossref_primary_10_1136_bmjopen_2024_086956 crossref_primary_10_1186_s12874_021_01364_0 crossref_primary_10_1186_s12879_016_1371_z crossref_primary_10_1111_acem_15063 crossref_primary_10_9778_cmajo_20190125 crossref_primary_10_1097_PTS_0000000000000910 crossref_primary_10_1016_j_clineuro_2024_108293 crossref_primary_10_1016_j_bjid_2020_08_004 crossref_primary_10_1136_tobaccocontrol_2017_053715 crossref_primary_10_1186_s12884_017_1318_4 crossref_primary_10_1097_BOT_0000000000002459 crossref_primary_10_1097_CCM_0000000000002449 crossref_primary_10_1136_bmjgh_2023_012752 crossref_primary_10_1016_j_abrep_2022_100407 crossref_primary_10_1542_peds_2017_4156 crossref_primary_10_3390_antibiotics12040659 crossref_primary_10_1002_pds_4804 crossref_primary_10_1016_j_lanwpc_2023_100968 crossref_primary_10_1136_bmjqs_2021_013910 crossref_primary_10_1186_s12936_017_2072_9 crossref_primary_10_1186_s13011_022_00505_y crossref_primary_10_1002_uog_23741 crossref_primary_10_1016_j_jclinepi_2014_12_018 crossref_primary_10_5334_ijic_4193 crossref_primary_10_1016_j_semarthrit_2017_09_006 crossref_primary_10_3390_antibiotics10050586 crossref_primary_10_1093_jpids_piw027 crossref_primary_10_1002_oby_21723 crossref_primary_10_1016_j_jclinepi_2017_02_017 crossref_primary_10_1111_add_15717 crossref_primary_10_1186_s13722_019_0160_6 crossref_primary_10_1136_bmjopen_2017_017626 crossref_primary_10_1097_AJP_0000000000000487 crossref_primary_10_1007_s10461_021_03197_w crossref_primary_10_1016_j_acap_2013_09_007 crossref_primary_10_2196_11735 crossref_primary_10_1186_s12913_019_4403_8 crossref_primary_10_1186_s12874_024_02184_8 crossref_primary_10_1007_s11605_015_3027_5 crossref_primary_10_1093_aje_kwae043 crossref_primary_10_1093_ehjqcco_qcaa027 crossref_primary_10_1093_intqhc_mzab061 crossref_primary_10_12688_gatesopenres_14591_2 crossref_primary_10_1016_j_amepre_2019_12_024 crossref_primary_10_1136_bmjgh_2020_003567 crossref_primary_10_12688_gatesopenres_14591_1 crossref_primary_10_1089_thy_2023_0651 crossref_primary_10_1016_j_socscimed_2017_05_040 crossref_primary_10_1136_bmjopen_2019_029188 crossref_primary_10_1513_AnnalsATS_202311_928OC crossref_primary_10_1136_oemed_2023_109276 crossref_primary_10_1093_jac_dkab073 crossref_primary_10_1136_injuryprev_2021_044321 crossref_primary_10_1136_bmjqs_2018_009068 crossref_primary_10_1093_cid_ciad115 crossref_primary_10_1016_j_conctc_2019_100474 crossref_primary_10_1111_ajt_16920 crossref_primary_10_1212_WNL_0000000000002452 crossref_primary_10_1016_j_chiabu_2021_105159 crossref_primary_10_1093_ageing_afy097 crossref_primary_10_1093_jpids_piw033 crossref_primary_10_1016_j_aap_2016_07_005 crossref_primary_10_1080_10810730_2018_1528318 crossref_primary_10_1186_s12916_022_02720_7 crossref_primary_10_1136_bmjopen_2023_082668 crossref_primary_10_1111_acem_12686 crossref_primary_10_1016_j_ijnurstu_2023_104604 crossref_primary_10_1001_jamahealthforum_2022_2534 crossref_primary_10_1001_jamanetworkopen_2020_22897 crossref_primary_10_1016_j_puhe_2018_06_006 crossref_primary_10_1016_j_aap_2020_105670 crossref_primary_10_1016_j_scitotenv_2020_141702 crossref_primary_10_1177_00219096251319219 crossref_primary_10_1080_20479700_2022_2051127 crossref_primary_10_1007_s00405_022_07308_8 crossref_primary_10_1200_CCI_21_00160 crossref_primary_10_1097_PRS_0000000000009974 crossref_primary_10_1371_journal_pone_0297187 crossref_primary_10_1016_j_cardfail_2023_06_005 crossref_primary_10_1136_bmjopen_2019_031054 crossref_primary_10_1177_0009922817738342 crossref_primary_10_1002_jrsm_1646 crossref_primary_10_1371_journal_pone_0237703 crossref_primary_10_1093_ije_dyaa148 crossref_primary_10_1186_s40545_022_00481_5 crossref_primary_10_5694_mja2_52566 crossref_primary_10_1002_pds_5032 crossref_primary_10_1136_bmjopen_2018_022279 crossref_primary_10_1136_bmjopen_2023_081158 crossref_primary_10_1186_s12889_017_4998_9 crossref_primary_10_1007_s00787_020_01607_3 crossref_primary_10_3390_medicina56120662 crossref_primary_10_1093_aje_kwad151 crossref_primary_10_1016_j_drugpo_2022_103770 crossref_primary_10_1159_000539062 crossref_primary_10_1016_j_jcjq_2023_05_003 crossref_primary_10_1001_jama_2018_8151 crossref_primary_10_1145_3555225 crossref_primary_10_1001_jamanetworkopen_2021_41353 crossref_primary_10_1093_intqhc_mzab006 crossref_primary_10_1002_jrsm_1669 crossref_primary_10_7326_M21_1436 crossref_primary_10_1002_sta4_302 crossref_primary_10_1371_journal_pone_0233318 crossref_primary_10_1371_journal_pgph_0002347 crossref_primary_10_4103_jphpc_jphpc_16_23 crossref_primary_10_1097_DCC_0000000000000268 crossref_primary_10_1111_anae_14600 crossref_primary_10_1136_jech_2017_208931 crossref_primary_10_2146_ajhp160872 crossref_primary_10_1016_j_amepre_2016_01_012 crossref_primary_10_1016_j_amepre_2024_05_011 crossref_primary_10_1097_HC9_0000000000000121 crossref_primary_10_1586_14760584_2015_1037289 crossref_primary_10_3390_youth4030082 crossref_primary_10_12688_f1000research_128094_1 crossref_primary_10_1371_journal_pmed_1002712 crossref_primary_10_1002_pds_4678 crossref_primary_10_1016_j_jvs_2019_08_244 crossref_primary_10_1097_MLR_0000000000000630 crossref_primary_10_1080_16549716_2020_1750216 crossref_primary_10_1177_10784535241307932 crossref_primary_10_1136_jech_2022_218941 crossref_primary_10_1186_s12873_021_00416_4 crossref_primary_10_1016_j_healthpol_2022_12_011 crossref_primary_10_1097_AOG_0000000000002680 crossref_primary_10_1016_j_gie_2023_04_2073 crossref_primary_10_1038_s41746_024_01371_7 crossref_primary_10_1245_s10434_023_13158_3 crossref_primary_10_1177_13623613231220687 crossref_primary_10_1371_journal_pone_0266651 crossref_primary_10_2106_JBJS_22_00955 crossref_primary_10_1001_jamanetworkopen_2023_24011 crossref_primary_10_1177_20514158211010651 crossref_primary_10_2147_RMHP_S456977 crossref_primary_10_1007_s40259_023_00589_3 crossref_primary_10_3389_fphar_2023_1129244 crossref_primary_10_1186_s13104_024_07055_5 crossref_primary_10_1016_j_jpag_2022_07_007 crossref_primary_10_1001_jamanetworkopen_2024_15383 crossref_primary_10_1093_gerona_glz143 crossref_primary_10_4269_ajtmh_16_0734 crossref_primary_10_1186_s13011_021_00349_y crossref_primary_10_1016_j_jpedsurg_2020_02_045 crossref_primary_10_1016_j_vaccine_2017_03_050 crossref_primary_10_1097_MLR_0000000000001700 crossref_primary_10_1016_j_acra_2020_12_022 crossref_primary_10_1007_s11292_017_9308_0 crossref_primary_10_1177_02676591211054978 crossref_primary_10_1186_s12998_023_00518_9 crossref_primary_10_3390_healthcare12020241 crossref_primary_10_1016_j_lana_2021_100163 crossref_primary_10_3390_ijerph192214647 crossref_primary_10_1177_01410768221095239 crossref_primary_10_1136_bmjopen_2017_017697 crossref_primary_10_1186_s12913_020_05378_0 crossref_primary_10_1177_1077558720952921 crossref_primary_10_1177_0897190019870949 crossref_primary_10_1136_bmj_2023_076175 crossref_primary_10_1038_srep31643 crossref_primary_10_2139_ssrn_3756821 crossref_primary_10_1002_hpm_3166 crossref_primary_10_1186_s13012_017_0703_8 crossref_primary_10_1002_jbmr_2882 crossref_primary_10_1186_1748_5908_9_77 crossref_primary_10_1177_1062860616689592 crossref_primary_10_1186_s12913_016_1730_x crossref_primary_10_3310_hsdr04170 crossref_primary_10_1186_s12875_024_02676_y crossref_primary_10_1542_hpeds_2017_0094 crossref_primary_10_1016_j_jmir_2020_03_001 crossref_primary_10_3390_healthcare9070873 crossref_primary_10_1093_eurpub_cky257 crossref_primary_10_1038_s41372_019_0416_8 crossref_primary_10_1108_IJHCQA_08_2015_0106 crossref_primary_10_1186_s12889_023_15499_w crossref_primary_10_1007_s11606_019_05206_0 crossref_primary_10_1212_CPJ_0000000000200419 crossref_primary_10_1016_j_jcjo_2021_05_013 crossref_primary_10_1177_01632787221119534 crossref_primary_10_5858_arpa_2016_0146_OA crossref_primary_10_1136_bmjopen_2022_064811 crossref_primary_10_1016_j_healthpol_2017_09_009 crossref_primary_10_1186_s13011_023_00537_y crossref_primary_10_1017_S1537592721002012 crossref_primary_10_1111_add_14643 crossref_primary_10_1186_s12966_020_00980_1 crossref_primary_10_1186_s12913_023_09845_2 crossref_primary_10_1007_s00125_015_3497_8 crossref_primary_10_1111_jgs_18208 crossref_primary_10_1136_emermed_2018_207571 crossref_primary_10_1016_j_ajic_2024_05_019 crossref_primary_10_32481_djph_2022_08_018 crossref_primary_10_1371_journal_pone_0179392 crossref_primary_10_1016_j_psychres_2019_06_027 crossref_primary_10_1016_j_chest_2023_12_025 crossref_primary_10_1089_tmj_2024_0595 crossref_primary_10_1007_s00198_014_3023_8 crossref_primary_10_1111_add_13326 crossref_primary_10_3389_feduc_2022_975092 crossref_primary_10_1111_aogs_14573 crossref_primary_10_1080_15389588_2019_1576035 crossref_primary_10_1097_NUR_0000000000000540 crossref_primary_10_1111_anae_14326 crossref_primary_10_1016_j_jopan_2021_11_019 crossref_primary_10_1111_acem_13450 crossref_primary_10_1007_s10900_020_00911_y crossref_primary_10_1302_0301_620X_100B1_BJJ_2017_0625_R2 crossref_primary_10_1097_QAI_0000000000001437 crossref_primary_10_1186_s40621_018_0165_8 crossref_primary_10_1080_14737167_2022_2035219 crossref_primary_10_1213_ANE_0000000000003977 crossref_primary_10_12788_jhm_3543 crossref_primary_10_1017_S0714980821000714 crossref_primary_10_1016_j_ufug_2023_127898 crossref_primary_10_1007_s11606_020_06317_9 crossref_primary_10_17269_s41997_024_00930_5 crossref_primary_10_1001_jamanetworkopen_2021_36662 crossref_primary_10_1111_hae_14250 crossref_primary_10_1093_jac_dkw055 crossref_primary_10_1001_jamapediatrics_2019_0067 crossref_primary_10_1007_s10115_021_01621_0 crossref_primary_10_1097_CCM_0000000000003286 crossref_primary_10_12688_f1000research_55004_2 crossref_primary_10_12688_f1000research_55004_1 crossref_primary_10_1136_bmjopen_2019_036371 crossref_primary_10_1016_j_jcjd_2023_08_005 crossref_primary_10_3389_fimmu_2022_932909 crossref_primary_10_1192_bjo_2021_1072 crossref_primary_10_1111_dar_13413 crossref_primary_10_1093_intqhc_mzy004 crossref_primary_10_1176_appi_ps_202000096 crossref_primary_10_53557_Elecciones_2022_v21n24_05 crossref_primary_10_17116__profmed20192206140 crossref_primary_10_2147_IJWH_S497100 crossref_primary_10_1002_epi4_12600 crossref_primary_10_1038_s41598_022_15569_w crossref_primary_10_1186_s13063_023_07273_5 crossref_primary_10_1136_bmjqs_2014_003756 crossref_primary_10_1002_bdr2_1878 crossref_primary_10_9778_cmajo_20180124 crossref_primary_10_2139_ssrn_3823830 crossref_primary_10_1177_0951484819868679 crossref_primary_10_3390_antibiotics10020136 crossref_primary_10_1016_S2215_0366_17_30209_2 crossref_primary_10_2105_AJPH_2017_304280 crossref_primary_10_3389_fphar_2022_861782 crossref_primary_10_1590_1413_81232022273_44562020 crossref_primary_10_1016_j_trpro_2024_12_047 crossref_primary_10_1016_j_soi_2024_100047 crossref_primary_10_1007_s10896_021_00344_8 crossref_primary_10_1016_j_jpeds_2020_01_061 crossref_primary_10_1186_s12936_021_04034_0 crossref_primary_10_3399_bjgp17X690437 crossref_primary_10_1007_s12325_021_01891_8 crossref_primary_10_1111_1475_6773_13630 crossref_primary_10_1177_03611981221107006 crossref_primary_10_1136_bmjqs_2017_007361 crossref_primary_10_1371_journal_pone_0219853 crossref_primary_10_2196_42857 crossref_primary_10_1016_j_resuscitation_2020_10_022 crossref_primary_10_1016_j_clinthera_2015_04_006 crossref_primary_10_1177_10732748231167254 crossref_primary_10_1001_jamanetworkopen_2022_10046 crossref_primary_10_1016_j_surg_2023_07_024 crossref_primary_10_1016_j_respe_2021_04_137 crossref_primary_10_1111_trf_13359 crossref_primary_10_1186_s12913_021_07432_x crossref_primary_10_1016_S2542_5196_19_30057_9 crossref_primary_10_1002_pds_4621 crossref_primary_10_1186_s12889_019_6514_x crossref_primary_10_12688_f1000research_22962_1 crossref_primary_10_1093_rheumatology_keab643 crossref_primary_10_1213_ANE_0000000000001532 crossref_primary_10_1016_j_aap_2021_106344 crossref_primary_10_1161_JAHA_123_030730 crossref_primary_10_12688_f1000research_22962_2 crossref_primary_10_1186_s12889_022_12858_x crossref_primary_10_1287_isre_2022_1178 crossref_primary_10_1001_jamainternmed_2021_7052 crossref_primary_10_1093_cid_cix590 crossref_primary_10_1109_JBHI_2022_3194207 crossref_primary_10_2147_RMHP_S263579 crossref_primary_10_1186_s12939_020_01246_9 crossref_primary_10_1186_s12967_020_02628_x crossref_primary_10_1016_j_amepre_2017_08_030 crossref_primary_10_1186_s12904_017_0200_5 crossref_primary_10_1001_jamaoto_2020_5233 crossref_primary_10_1186_s12883_023_03295_3 crossref_primary_10_1213_ANE_0000000000004805 crossref_primary_10_3390_antibiotics13040356 crossref_primary_10_1080_15389588_2020_1810246 crossref_primary_10_1093_cid_ciaa720 crossref_primary_10_1093_cid_ciaa962 crossref_primary_10_3389_fpubh_2022_937644 crossref_primary_10_3390_healthcare12050518 crossref_primary_10_1136_bmjgh_2023_013679 crossref_primary_10_1177_00333549241288140 crossref_primary_10_1371_journal_pone_0308482 crossref_primary_10_1111_1742_6723_13981 crossref_primary_10_1136_bmjopen_2014_006547 crossref_primary_10_1136_bmjph_2024_001576 crossref_primary_10_1007_s10754_020_09282_2 crossref_primary_10_12788_jhm_3576 crossref_primary_10_1186_s12913_017_2434_6 crossref_primary_10_1016_j_amepre_2023_11_008 crossref_primary_10_1016_j_socscimed_2021_113685 crossref_primary_10_1007_s00134_017_4771_7 crossref_primary_10_1186_s12872_023_03614_z crossref_primary_10_1038_s41372_022_01334_4 crossref_primary_10_1513_AnnalsATS_202205_467RL crossref_primary_10_1016_j_aap_2020_105747 crossref_primary_10_2105_AJPH_2020_305748 crossref_primary_10_1002_bdr2_1578 crossref_primary_10_1186_s13011_023_00587_2 crossref_primary_10_1016_j_cct_2015_08_010 crossref_primary_10_1016_j_ajic_2020_08_014 crossref_primary_10_1017_ash_2022_1 crossref_primary_10_1186_s12913_019_4690_0 crossref_primary_10_1186_s12913_019_4045_x crossref_primary_10_1371_journal_pone_0151073 crossref_primary_10_1007_s11524_020_00422_0 crossref_primary_10_1161_CIRCULATIONAHA_118_036528 crossref_primary_10_1542_peds_2024_068065 crossref_primary_10_1186_s12875_021_01528_3 crossref_primary_10_3389_ijph_2022_1604319 crossref_primary_10_1016_j_lana_2024_100774 crossref_primary_10_1111_nyas_13093 crossref_primary_10_1001_jamanetworkopen_2024_0503 crossref_primary_10_3934_medsci_2021003 crossref_primary_10_1377_hlthaff_2017_0684 crossref_primary_10_1080_15481603_2020_1868212 crossref_primary_10_1371_journal_pone_0231070 crossref_primary_10_1371_journal_pmed_1003269 crossref_primary_10_1287_msom_2022_0455 crossref_primary_10_1016_j_drugpo_2022_103680 crossref_primary_10_1177_0306624X17703719 crossref_primary_10_7861_clinmedicine_19_4_290 crossref_primary_10_1097_pq9_0000000000000026 crossref_primary_10_1097_CEH_0000000000000277 crossref_primary_10_1016_j_amepre_2019_09_002 crossref_primary_10_1007_s11606_020_06276_1 crossref_primary_10_1080_09638288_2024_2335662 crossref_primary_10_1186_s12913_020_05427_8 crossref_primary_10_1016_j_jclinepi_2017_07_008 crossref_primary_10_1097_CCM_0000000000004798 crossref_primary_10_1016_j_sste_2024_100662 crossref_primary_10_1111_jvh_13723 crossref_primary_10_1186_s12884_021_03816_3 crossref_primary_10_29105_cc2_3_23 crossref_primary_10_1016_j_worlddev_2024_106787 crossref_primary_10_7326_M19_0875 crossref_primary_10_1136_bmjoq_2020_001106 crossref_primary_10_1016_j_jogc_2021_12_006 crossref_primary_10_1164_rccm_202203_0496OC crossref_primary_10_1016_j_acap_2021_02_009 crossref_primary_10_1142_S1793557122502473 crossref_primary_10_1007_s11606_016_3833_9 crossref_primary_10_1186_s12913_020_05391_3 crossref_primary_10_1186_s12913_020_05952_6 crossref_primary_10_3389_fpubh_2022_1021177 crossref_primary_10_1017_ice_2024_144 crossref_primary_10_1093_pch_pxae079 crossref_primary_10_1002_sim_7443 crossref_primary_10_1016_S0140_6736_23_00497_X crossref_primary_10_1186_s12913_021_06399_z crossref_primary_10_1016_j_arth_2020_09_054 crossref_primary_10_1016_j_cmpb_2020_105315 crossref_primary_10_3390_healthcare7040116 crossref_primary_10_1136_bmjopen_2019_029492 crossref_primary_10_1542_peds_2021_049972 crossref_primary_10_1007_s11606_020_06210_5 crossref_primary_10_1097_MLR_0000000000001369 crossref_primary_10_1111_jrh_12538 crossref_primary_10_1017_ice_2022_69 crossref_primary_10_1177_17446295241307061 crossref_primary_10_1111_jgs_14322 crossref_primary_10_1371_journal_pone_0266160 crossref_primary_10_5662_wjm_v13_i5_446 crossref_primary_10_1186_s13012_022_01224_5 crossref_primary_10_3389_fped_2022_864029 crossref_primary_10_3390_jpm12020178 crossref_primary_10_1093_eurheartj_ehw232 crossref_primary_10_1136_tsaco_2022_001062 crossref_primary_10_1177_0036933015597178 crossref_primary_10_1186_s12913_022_08337_z crossref_primary_10_1093_jamia_ocx154 crossref_primary_10_2196_resprot_4024 crossref_primary_10_1038_s41598_023_33929_y crossref_primary_10_1186_s12874_020_01200_x crossref_primary_10_1016_j_ajic_2020_08_021 crossref_primary_10_1186_s12874_024_02448_3 crossref_primary_10_1007_s11222_023_10295_3 crossref_primary_10_1186_s12879_016_1426_1 crossref_primary_10_1186_s13011_021_00366_x crossref_primary_10_1089_cap_2024_0007 crossref_primary_10_1097_TXD_0000000000001706 crossref_primary_10_1186_s12913_021_07059_y crossref_primary_10_53455_re_v6i_256 crossref_primary_10_1136_bmjopen_2018_024514 crossref_primary_10_1016_j_ijnurstu_2020_103611 crossref_primary_10_1213_ANE_0000000000002117 crossref_primary_10_1007_s11926_020_00907_6 crossref_primary_10_1542_hpeds_2018_0099 crossref_primary_10_1016_j_ekir_2016_12_004 crossref_primary_10_1542_hpeds_2021_005814 crossref_primary_10_1007_s40267_024_01110_8 crossref_primary_10_1093_cid_ciad261 crossref_primary_10_1097_SLA_0000000000005231 crossref_primary_10_1176_appi_ps_201800163 crossref_primary_10_1080_20008198_2017_1378053 crossref_primary_10_12688_wellcomeopenres_15810_1 crossref_primary_10_1186_s12884_024_06482_3 crossref_primary_10_12688_wellcomeopenres_15810_2 crossref_primary_10_1055_s_0040_1715828 crossref_primary_10_1093_aje_kwad061 crossref_primary_10_3390_medicina60081338 crossref_primary_10_1093_jamia_ocab038 crossref_primary_10_1371_journal_pmed_1003089 crossref_primary_10_1177_29767342241243309 crossref_primary_10_1681_ASN_2022040471 crossref_primary_10_1186_s41256_023_00312_3 crossref_primary_10_1016_j_whi_2024_03_006 crossref_primary_10_1093_cid_ciab073 crossref_primary_10_9778_cmajo_20210185 crossref_primary_10_1136_bmjgh_2015_000020 crossref_primary_10_1213_ANE_0000000000004153 crossref_primary_10_1016_j_japwor_2024_101240 crossref_primary_10_1097_PCC_0000000000002744 crossref_primary_10_3233_IDT_240224 crossref_primary_10_1089_jwh_2020_8546 crossref_primary_10_1097_MLR_0000000000001318 crossref_primary_10_1136_bmjopen_2018_023446 crossref_primary_10_1007_s11606_020_06476_9 crossref_primary_10_1097_HCR_0000000000000255 crossref_primary_10_1016_j_jgar_2021_11_001 crossref_primary_10_1016_j_burns_2019_12_012 crossref_primary_10_1007_s12561_022_09346_6 crossref_primary_10_1016_j_drugalcdep_2024_111125 crossref_primary_10_1590_0102_311xen031524 crossref_primary_10_3390_ijerph18116033 crossref_primary_10_1017_ice_2020_12 crossref_primary_10_1111_1742_6723_13151 crossref_primary_10_2139_ssrn_4160682 crossref_primary_10_1111_birt_12606 crossref_primary_10_1111_jpc_14384 crossref_primary_10_1038_s41366_021_00900_8 crossref_primary_10_1016_j_kint_2021_04_020 crossref_primary_10_2196_39181 crossref_primary_10_1186_s12874_021_01306_w crossref_primary_10_1080_10903127_2019_1679303 crossref_primary_10_1158_1055_9965_EPI_23_0813 crossref_primary_10_1136_bmjopen_2021_051233 crossref_primary_10_1016_j_healthpol_2025_105270 crossref_primary_10_1136_bmjopen_2022_070031 crossref_primary_10_1177_23259582211041260 crossref_primary_10_1007_s12103_024_09783_7 crossref_primary_10_1093_jac_dkab180 crossref_primary_10_1186_s12913_022_08331_5 crossref_primary_10_3390_ijerph182413253 crossref_primary_10_4081_ecj_2020_9201 crossref_primary_10_1371_journal_pone_0311052 crossref_primary_10_1186_s13012_015_0346_6 crossref_primary_10_1017_S0033291722001155 crossref_primary_10_1177_2333794X20987444 crossref_primary_10_1371_journal_pntd_0009420 crossref_primary_10_1111_1468_0009_12314 crossref_primary_10_1038_s41391_022_00628_0 crossref_primary_10_1111_add_13860 crossref_primary_10_1186_s12913_023_09557_7 crossref_primary_10_1111_jvh_13980 crossref_primary_10_1016_j_tranpol_2022_05_005 crossref_primary_10_1186_s12913_020_05397_x crossref_primary_10_1093_intqhc_mzab113 crossref_primary_10_4178_epih_e2023020 crossref_primary_10_1016_j_ssmph_2019_100350 crossref_primary_10_1111_ejed_12356 crossref_primary_10_1016_j_jcjo_2021_06_005 crossref_primary_10_3389_fpubh_2024_1386667 crossref_primary_10_1016_j_acap_2021_10_014 crossref_primary_10_3389_fpubh_2021_504998 crossref_primary_10_1097_MLR_0000000000001739 crossref_primary_10_1038_s41440_023_01373_0 crossref_primary_10_1109_ACCESS_2018_2840086 crossref_primary_10_1016_j_jamda_2021_04_005 crossref_primary_10_1093_cid_ciy902 crossref_primary_10_1186_s12888_019_2147_y crossref_primary_10_3390_ijerph182010794 crossref_primary_10_1016_j_jenvp_2018_08_001 crossref_primary_10_1053_j_gastro_2022_03_013 crossref_primary_10_3390_traumacare5020005 crossref_primary_10_1007_s43441_022_00379_z crossref_primary_10_29045_14784726_2022_06_7_1_9 crossref_primary_10_1016_j_ssmph_2016_07_002 crossref_primary_10_3310_hsdr04250 crossref_primary_10_1097_CCE_0000000000000889 crossref_primary_10_1016_j_chest_2022_04_147 crossref_primary_10_1016_j_drugpo_2019_07_018 crossref_primary_10_1016_j_ajem_2024_07_036 crossref_primary_10_1371_journal_pone_0138303 crossref_primary_10_1155_2021_9498029 crossref_primary_10_1111_dar_13921 crossref_primary_10_1001_jamanetworkopen_2021_37238 crossref_primary_10_1016_j_glt_2023_12_001 crossref_primary_10_1186_s12889_020_08746_x crossref_primary_10_3389_fpsyg_2024_1431184 crossref_primary_10_1002_sim_8067 crossref_primary_10_1016_j_jadohealth_2024_09_006 crossref_primary_10_1136_bmjgh_2020_002879 crossref_primary_10_1080_21645515_2022_2094641 crossref_primary_10_1136_emermed_2014_204479 crossref_primary_10_1111_chd_12508 crossref_primary_10_1016_j_jadohealth_2023_01_019 crossref_primary_10_1007_s10488_021_01175_x crossref_primary_10_1016_j_injury_2019_08_022 crossref_primary_10_1542_peds_2018_3243 crossref_primary_10_1371_journal_pone_0306395 crossref_primary_10_1007_s10916_018_1061_z crossref_primary_10_18273_revsal_v52n1_2020003 crossref_primary_10_1097_SLA_0000000000004635 crossref_primary_10_3390_ijerph16081410 crossref_primary_10_1016_j_jstrokecerebrovasdis_2022_106900 crossref_primary_10_57264_cer_2023_0110 crossref_primary_10_1093_eurheartj_ehz152 crossref_primary_10_1016_j_jsat_2021_108687 crossref_primary_10_1542_peds_2017_1765 crossref_primary_10_9778_cmajo_20200084 crossref_primary_10_1007_s00127_023_02446_8 crossref_primary_10_1016_j_cities_2023_104711 crossref_primary_10_3399_BJGPO_2022_0089 crossref_primary_10_1590_1980_549720200047 crossref_primary_10_1371_journal_pmed_1002867 crossref_primary_10_3310_hsdr04280 crossref_primary_10_1016_j_jpeds_2023_113582 crossref_primary_10_1001_jamanetworkopen_2022_42354 crossref_primary_10_1371_journal_pmed_1002863 crossref_primary_10_1016_j_vaccine_2017_11_041 crossref_primary_10_1136_bmjpo_2022_001686 crossref_primary_10_33396_1728_0869_2020_5_37_44 crossref_primary_10_1186_s12874_023_02098_x crossref_primary_10_1371_journal_pone_0219567 crossref_primary_10_1377_hlthaff_2021_00791 crossref_primary_10_1371_journal_pmed_1003729 crossref_primary_10_1016_j_semperi_2020_151244 crossref_primary_10_1097_SLA_0000000000003521 crossref_primary_10_1016_j_drugalcdep_2020_107923 crossref_primary_10_1097_MLR_0000000000000937 crossref_primary_10_1371_journal_pone_0243424 crossref_primary_10_1016_S2589_7500_23_00108_5 crossref_primary_10_1177_00220574221110477 crossref_primary_10_1111_add_14798 crossref_primary_10_1016_j_whi_2015_03_002 crossref_primary_10_1111_jcpp_13800 crossref_primary_10_1542_peds_2022_057176 crossref_primary_10_2147_CLEP_S387461 crossref_primary_10_2147_IDR_S322938 crossref_primary_10_2196_17363 crossref_primary_10_1016_j_jclinepi_2020_02_006 crossref_primary_10_1016_j_heliyon_2024_e32750 crossref_primary_10_17269_CJPH_106_5148 crossref_primary_10_1016_j_envint_2019_04_009 crossref_primary_10_1177_10497315241305779 crossref_primary_10_1111_acem_14881 crossref_primary_10_1371_journal_pone_0137448 crossref_primary_10_1093_cid_ciaa456 crossref_primary_10_1007_s11280_024_01251_w crossref_primary_10_1186_s12913_018_3411_4 crossref_primary_10_1186_s13012_017_0702_9 crossref_primary_10_1186_s13012_021_01117_z crossref_primary_10_1056_CAT_22_0162 crossref_primary_10_1007_s11606_021_07178_6 crossref_primary_10_1111_anae_14451 crossref_primary_10_1542_peds_2021_052201 crossref_primary_10_1111_add_14778 crossref_primary_10_1111_add_14536 crossref_primary_10_1097_PTS_0000000000000370 crossref_primary_10_1177_08874034241303024 crossref_primary_10_1176_appi_ps_201500543 crossref_primary_10_1136_bmjoq_2024_003142 crossref_primary_10_1097_OLQ_0000000000001833 crossref_primary_10_1136_bmjopen_2017_019315 crossref_primary_10_1002_sgp2_12105 crossref_primary_10_1016_j_jad_2014_12_050 crossref_primary_10_1002_jmv_29660 crossref_primary_10_2196_58276 crossref_primary_10_1161_CIRCOUTCOMES_121_008040 crossref_primary_10_1007_s40258_015_0169_2 crossref_primary_10_4037_ajcc2020272 crossref_primary_10_1016_j_jcjd_2021_12_002 crossref_primary_10_1016_j_jclinepi_2015_10_013 crossref_primary_10_1177_00333549241236629 crossref_primary_10_3389_fpubh_2021_729778 crossref_primary_10_1002_jhm_13093 crossref_primary_10_2478_jcbtp_2019_0014 crossref_primary_10_1016_j_vaccine_2017_03_105 crossref_primary_10_1016_j_amjmed_2016_01_024 crossref_primary_10_2139_ssrn_4123949 crossref_primary_10_1016_j_eururo_2016_03_015 crossref_primary_10_1097_QAD_0000000000001531 crossref_primary_10_12788_jhm_3423 crossref_primary_10_1186_s12874_021_01322_w crossref_primary_10_1093_cid_ciy752 crossref_primary_10_1016_j_jpeds_2015_01_015 crossref_primary_10_1016_j_iccn_2017_01_008 crossref_primary_10_1093_jamia_ocy112 crossref_primary_10_1097_AOG_0000000000003010 crossref_primary_10_1371_journal_pmed_1003537 crossref_primary_10_1111_1475_6773_13564 crossref_primary_10_1093_cid_ciac834 crossref_primary_10_1080_15389588_2024_2351204 crossref_primary_10_1002_lrh2_10344 crossref_primary_10_1371_journal_pone_0301301 crossref_primary_10_1093_pm_pnx293 crossref_primary_10_1371_journal_pone_0193902 crossref_primary_10_1177_00207640231194484 crossref_primary_10_1177_2309499020935996 crossref_primary_10_1016_j_cmi_2017_05_019 crossref_primary_10_1016_j_aap_2018_12_001 crossref_primary_10_1136_bmjopen_2020_048271 crossref_primary_10_1002_jcph_825 crossref_primary_10_1186_s12916_022_02497_9 crossref_primary_10_1542_hpeds_2019_0284 crossref_primary_10_1007_s10654_024_01122_8 crossref_primary_10_1001_jamanetworkopen_2023_55239 crossref_primary_10_1177_0009922817734363 crossref_primary_10_1016_j_cct_2021_106377 crossref_primary_10_1016_j_healthpol_2020_05_001 crossref_primary_10_1002_lrh2_10358 crossref_primary_10_1186_s12889_021_11236_3 crossref_primary_10_1097_PEC_0000000000002404 crossref_primary_10_1016_j_drugalcdep_2019_05_025 crossref_primary_10_1097_AOG_0000000000005412 crossref_primary_10_1177_08971900221118159 crossref_primary_10_1136_bmjoq_2024_002925 crossref_primary_10_1136_bmjopen_2021_056125 crossref_primary_10_1007_s10995_019_02783_8 crossref_primary_10_1111_liv_15074 crossref_primary_10_1016_j_petrol_2018_08_068 crossref_primary_10_1513_AnnalsATS_202102_121OC crossref_primary_10_1002_sim_7392 crossref_primary_10_12788_jhm_3417 crossref_primary_10_1002_vetr_1485 crossref_primary_10_1093_pnasnexus_pgad320 crossref_primary_10_17533_udea_iatreia_v30n3a11 crossref_primary_10_1371_journal_pone_0179222 crossref_primary_10_1093_ejcts_ezac370 crossref_primary_10_1111_acem_14256 crossref_primary_10_1002_pds_5847 crossref_primary_10_1016_j_jpeds_2022_10_036 crossref_primary_10_1016_j_ajem_2015_08_039 crossref_primary_10_1093_milmed_usae304 crossref_primary_10_3390_jcdd10030102 crossref_primary_10_1001_jamapediatrics_2018_5273 crossref_primary_10_1016_j_chiabu_2023_106186 crossref_primary_10_1590_s1806_37562018000000096 crossref_primary_10_1177_0275074016685804 crossref_primary_10_1186_s12913_023_09158_4 crossref_primary_10_3389_fphar_2022_842944 crossref_primary_10_1007_s10618_024_01075_2 crossref_primary_10_3389_fpubh_2022_1072493 crossref_primary_10_1186_s40621_021_00298_x crossref_primary_10_1016_j_puhe_2023_09_016 crossref_primary_10_1093_heapol_czy104 crossref_primary_10_1177_0272989X18818165 crossref_primary_10_1542_peds_2018_2116 crossref_primary_10_1176_appi_ps_201600489 crossref_primary_10_1016_j_hpopen_2021_100044 crossref_primary_10_1017_ice_2016_22 crossref_primary_10_1002_iid3_630 crossref_primary_10_1017_cem_2018_10 crossref_primary_10_1016_j_chstcc_2024_100059 crossref_primary_10_1007_s11606_023_08238_9 crossref_primary_10_1111_ijcp_13316 crossref_primary_10_1136_archdischild_2022_323802 crossref_primary_10_1186_s12888_017_1220_7 crossref_primary_10_1542_peds_2020_045948F crossref_primary_10_1093_rap_rkaa079 crossref_primary_10_1186_s40621_021_00308_y crossref_primary_10_1016_j_jcjq_2022_08_005 crossref_primary_10_1097_JHM_D_23_00031 crossref_primary_10_2196_51412 crossref_primary_10_1111_ppe_12984 crossref_primary_10_3390_ijerph19095364 crossref_primary_10_1186_s12913_019_4462_x crossref_primary_10_1093_milmed_usaa176 crossref_primary_10_1016_j_vaccine_2021_10_067 crossref_primary_10_1002_lrh2_10315 crossref_primary_10_1590_1980_549720210045 crossref_primary_10_1371_journal_pmed_1003596 crossref_primary_10_3389_frph_2022_811429 |
| Cites_doi | 10.2105/AJPH.71.1.38 10.1002/pds.1509 10.1007/s40272-012-0001-5 10.1097/01.chi.0000235077.32661.61 10.1046/j.1365-2710.2002.00430.x 10.1176/appi.ps.60.4.520 10.1097/MLR.0b013e3182162afb 10.1377/hlthaff.27.3.w185 10.1001/jama.2010.1692 10.1001/archpediatrics.2011.1269 10.1001/archinternmed.2009.39 10.1097/MLR.0b013e3180616c0a 10.1176/appi.ps.201100207 10.1023/A:1010024016308 10.1056/NEJM198708273170906 10.1097/CHI.0b013e3181a2b2ed 10.1097/MLR.0b013e31826c86f1 10.1177/1087054709344194 10.1016/j.jclinepi.2008.08.007 10.1002/sim.3780 10.1177/0193841X9702100205 10.1056/NEJM199409083311006 10.1056/NEJM199110103251505 10.1001/jama.1990.03440060077036 10.1001/2013.jamapediatrics.47 10.1002/pds.2320 |
| ContentType | Journal Article |
| Copyright | 2013 Academic Pediatric Association Academic Pediatric Association Copyright © 2013 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2013 Academic Pediatric Association – notice: Academic Pediatric Association – notice: Copyright © 2013 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.acap.2013.08.002 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1876-2867 |
| EndPage | S44 |
| ExternalDocumentID | 24268083 10_1016_j_acap_2013_08_002 S1876285913002106 1_s2_0_S1876285913002106 |
| Genre | Research Support, U.S. Gov't, P.H.S Review Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | --- --K --M .1- .FO .~1 04C 0R~ 1B1 1P~ 1~. 23M 36B 4.4 457 4G. 53G 5VS 6J9 7-5 7RQ 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8P~ 8R4 8R5 AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ABPPZ ABUWG ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADIXH ADMUD ADNMO ADVLN AEBSH AEFWE AEGXH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFKRA AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR AZQEC BENPR BKEYQ BKOJK BLXMC BMSDO BNPGV BPHCQ BVXVI C1A CCPQU DWQXO EBD EBS EFJIC EFKBS EIHBH EJD EMB EMOBN EX3 F5P FDB FEDTE FIRID FNPLU FYGXN FYUFA GBLVA GNUQQ GUQSH HMCUK HVGLF HX~ HZ~ J1W KOM M1P M2O M41 MO0 N9A NAPCQ O-L O9- OAUVE OH- OZT P-8 P-9 PADUT PC. PCD PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q2X Q38 ROL SDF SEL SES SPCBC SSH SSZ SV3 T5K UKHRP UNMZH WOW Z5R ~G- 3V. AACTN AFCTW AFKWA AJOXV ALIPV AMFUW AAIAV AAQFI ABLVK ABYKQ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c528t-1cb6fb093df0becab5a4d800fa2707c5ee43d3aa69adf4013ca52acf0943542e3 |
| IEDL.DBID | .~1 |
| ISSN | 1876-2859 1876-2867 |
| IngestDate | Fri Jul 11 15:41:47 EDT 2025 Mon Jul 21 06:03:59 EDT 2025 Tue Jul 01 03:46:24 EDT 2025 Thu Apr 24 23:09:21 EDT 2025 Fri Feb 23 02:09:27 EST 2024 Sun Feb 23 10:19:50 EST 2025 Tue Aug 26 16:31:31 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | interrupted time series research design quasi-experimental quality improvement |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2013 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c528t-1cb6fb093df0becab5a4d800fa2707c5ee43d3aa69adf4013ca52acf0943542e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 24268083 |
| PQID | 1465859186 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1465859186 pubmed_primary_24268083 crossref_citationtrail_10_1016_j_acap_2013_08_002 crossref_primary_10_1016_j_acap_2013_08_002 elsevier_sciencedirect_doi_10_1016_j_acap_2013_08_002 elsevier_clinicalkeyesjournals_1_s2_0_S1876285913002106 elsevier_clinicalkey_doi_10_1016_j_acap_2013_08_002 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2013-11-01 |
| PublicationDateYYYYMMDD | 2013-11-01 |
| PublicationDate_xml | – month: 11 year: 2013 text: 2013-11-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Academic pediatrics |
| PublicationTitleAlternate | Acad Pediatr |
| PublicationYear | 2013 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Fan, Laupacis, Pronovost (bib5) 2010; 304 SAS Washington, DC; American Statistical Association. 1987:488–493. Brown, Kulldorff, Chan (bib31) 2007; 16 Wagner, Soumerai, Zhang (bib4) 2002; 27 Hilt, Romaire, McDonell (bib22) 2013; 167 Gruenewald (bib1) 1997; 21 Greenhill, Kollins, Abikoff (bib21) 2006; 45 Lieu, Kulldorff, Davis (bib34) 2007; 45 McDowall, McCleary, Meidinger (bib10) 1980 Wolraich, Bard, Stein (bib20) 2010; 13 Soumerai, McLaughlin, Ross-Degnan (bib6) 1994; 331 Shadish, Cook, Campbell (bib3) 2002 Soumerai, Zhang, Ross-Degnan (bib13) 2008; 27 Bobbit LG, Otto MC. Effects of forecasts on the revisions of seasonally adjusted data using the X-11 adjustment procedure. In Biglan, Ary, Wagenaar (bib2) 2000; 1 Subcommittee on Attention-deficit/Hyperactivity Disorder Steering Committee on Quality Improvement and Management (bib18) 2011; 128 Hacker, Penfold, Zhang (bib29) 2012; 63 Thompson, Varley, McClellan (bib23) 2009; 48 Cary, NC: SAS Institute; 2008. Available at Zhang, Wagner, Soumerai (bib30) 2009; 62 Briesacher, Zhao, Madden (bib11) 2011; 49 Accessed July 25, 2013. Rodgers, Topping (bib17) 2012; 166 Buszuwski JA. Alternative ARIMA forecasting horizons when seasonally adjusting producer price data with X-11-ARIMA. In Gillings, Makuc, Siegel (bib9) 1981; 71 Hilt R. Partnership access line Washington. Available at Hilt R. Primary care principles for child mental health, version 4.0. Available at Adams, Zhang, LeCates (bib12) 2009; 169 Soumerai, Avorn, Ross-Degnan (bib8) 1987; 317 The AUTOREG procedure. In Soumerai, Ross-Degnan, Gortmaker (bib7) 1990; 263 Zhang, Adams, Ross-Degnan (bib14) 2009; 60 Accessed July 26, 2013. Du, Zhou, Goldsmith (bib16) 2012; 50 1990:449–453. Washington, DC; American Statistical Association. Accessed July 26, 2013. Pages 313–428. Cook, Tiwari, Wellman (bib32) 2012; 21 Li, Kulldorff (bib33) 2010; 29 Soumerai, Ross-Degnan, Avorn (bib15) 1991; 325 Ghuman, Ghuman (bib19) 2013; 15 Gruenewald (10.1016/j.acap.2013.08.002_bib1) 1997; 21 Thompson (10.1016/j.acap.2013.08.002_bib23) 2009; 48 10.1016/j.acap.2013.08.002_bib25 Ghuman (10.1016/j.acap.2013.08.002_bib19) 2013; 15 10.1016/j.acap.2013.08.002_bib26 10.1016/j.acap.2013.08.002_bib27 10.1016/j.acap.2013.08.002_bib28 Zhang (10.1016/j.acap.2013.08.002_bib14) 2009; 60 Gillings (10.1016/j.acap.2013.08.002_bib9) 1981; 71 Subcommittee on Attention-deficit/Hyperactivity Disorder Steering Committee on Quality Improvement and Management (10.1016/j.acap.2013.08.002_bib18) 2011; 128 10.1016/j.acap.2013.08.002_bib24 Briesacher (10.1016/j.acap.2013.08.002_bib11) 2011; 49 Adams (10.1016/j.acap.2013.08.002_bib12) 2009; 169 Hacker (10.1016/j.acap.2013.08.002_bib29) 2012; 63 Brown (10.1016/j.acap.2013.08.002_bib31) 2007; 16 Biglan (10.1016/j.acap.2013.08.002_bib2) 2000; 1 Hilt (10.1016/j.acap.2013.08.002_bib22) 2013; 167 Wagner (10.1016/j.acap.2013.08.002_bib4) 2002; 27 Fan (10.1016/j.acap.2013.08.002_bib5) 2010; 304 Zhang (10.1016/j.acap.2013.08.002_bib30) 2009; 62 Soumerai (10.1016/j.acap.2013.08.002_bib7) 1990; 263 Li (10.1016/j.acap.2013.08.002_bib33) 2010; 29 Wolraich (10.1016/j.acap.2013.08.002_bib20) 2010; 13 McDowall (10.1016/j.acap.2013.08.002_bib10) 1980 Cook (10.1016/j.acap.2013.08.002_bib32) 2012; 21 Shadish (10.1016/j.acap.2013.08.002_bib3) 2002 Greenhill (10.1016/j.acap.2013.08.002_bib21) 2006; 45 Lieu (10.1016/j.acap.2013.08.002_bib34) 2007; 45 Soumerai (10.1016/j.acap.2013.08.002_bib13) 2008; 27 Soumerai (10.1016/j.acap.2013.08.002_bib15) 1991; 325 Soumerai (10.1016/j.acap.2013.08.002_bib8) 1987; 317 Rodgers (10.1016/j.acap.2013.08.002_bib17) 2012; 166 Soumerai (10.1016/j.acap.2013.08.002_bib6) 1994; 331 Du (10.1016/j.acap.2013.08.002_bib16) 2012; 50 |
| References_xml | – volume: 325 start-page: 1072 year: 1991 end-page: 1077 ident: bib15 article-title: Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes publication-title: N Engl J Med – reference: . Cary, NC: SAS Institute; 2008. Available at: – reference: Hilt R. Partnership access line Washington. Available at: – volume: 167 start-page: 162 year: 2013 end-page: 168 ident: bib22 article-title: The Partnership Access Line: evaluating a child psychiatry consult program in Washington State publication-title: JAMA Pediatr – volume: 304 start-page: 2279 year: 2010 end-page: 2287 ident: bib5 article-title: How to use an article about quality improvement publication-title: JAMA – volume: 16 start-page: 1275 year: 2007 end-page: 1284 ident: bib31 article-title: Early detection of adverse drug events within population-based health networks: application of sequential testing methods publication-title: Pharmacoepidemiol Drug Saf – reference: Buszuwski JA. Alternative ARIMA forecasting horizons when seasonally adjusting producer price data with X-11-ARIMA. In: – volume: 62 start-page: 143 year: 2009 end-page: 148 ident: bib30 article-title: Methods for estimating confidence intervals in interrupted time series analyses of health interventions publication-title: J Clin Epidemiol – volume: 169 start-page: 750 year: 2009 end-page: 756 ident: bib12 article-title: Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees publication-title: Arch Intern Med – volume: 331 start-page: 650 year: 1994 end-page: 655 ident: bib6 article-title: Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia publication-title: N Engl J Med – volume: 21 start-page: 72 year: 2012 end-page: 81 ident: bib32 article-title: Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini-Sentinel pilot publication-title: Pharmacoepidemiol Drug Saf – reference: Bobbit LG, Otto MC. Effects of forecasts on the revisions of seasonally adjusted data using the X-11 adjustment procedure. In: – volume: 60 start-page: 520 year: 2009 end-page: 527 ident: bib14 article-title: Effects of prior authorization on medication discontinuation among Medicaid beneficiaries with bipolar disorder publication-title: Psychiatr Serv – reference: SAS – volume: 48 start-page: 740 year: 2009 end-page: 748 ident: bib23 article-title: Second opinions improve ADHD prescribing in a Medicaid-insured community population publication-title: J Am Acad Child Adolesc Psychiatry – reference: . Accessed July 26, 2013. Pages 313–428. – volume: 27 start-page: w185 year: 2008 end-page: w195 ident: bib13 article-title: Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change publication-title: Health Aff (Millwood) – volume: 13 start-page: 563 year: 2010 end-page: 572 ident: bib20 article-title: Pediatricians’ attitudes and practices on ADHD before and after the development of ADHD pediatric practice guidelines publication-title: J Atten Disord – volume: 128 start-page: 2011 year: 2011 end-page: 2654 ident: bib18 article-title: ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents publication-title: Pediatrics – volume: 45 start-page: 1284 year: 2006 end-page: 1293 ident: bib21 article-title: Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD publication-title: J Am Acad Child Adolesc Psychiatry – volume: 63 start-page: 256 year: 2012 end-page: 261 ident: bib29 article-title: Impact of electronic health record transition on behavioral health screening in a large pediatric practice publication-title: Psychiatr Serv – year: 1980 ident: bib10 article-title: Interrupted Time Series Analysis – reference: . Accessed July 26, 2013. – volume: 21 start-page: 209 year: 1997 end-page: 230 ident: bib1 article-title: Analysis approaches to community evaluation publication-title: Eval Rev – volume: 1 start-page: 31 year: 2000 end-page: 49 ident: bib2 article-title: The value of interrupted time-series experiments for community intervention research publication-title: Prev Sci – reference: . Accessed July 25, 2013. – reference: The AUTOREG procedure. In: – volume: 15 start-page: 1 year: 2013 end-page: 8 ident: bib19 article-title: Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers: is it justified? publication-title: Paediatr Drugs – volume: 71 start-page: 38 year: 1981 end-page: 46 ident: bib9 article-title: Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care publication-title: Am J Public Health – volume: 27 start-page: 299 year: 2002 end-page: 309 ident: bib4 article-title: Segmented regression analysis of interrupted time series studies in medication use research publication-title: J Clin Pharm Ther – reference: . 1990:449–453. Washington, DC; American Statistical Association. – volume: 166 start-page: 651 year: 2012 end-page: 655 ident: bib17 article-title: Safety effects of drawstring requirements for children’s upper outerwear garments publication-title: Arch Pediatr Adolesc Med – reference: . Washington, DC; American Statistical Association. 1987:488–493. – volume: 50 start-page: 987 year: 2012 end-page: 992 ident: bib16 article-title: Atomoxetine use during a period of FDA actions publication-title: Med Care – volume: 29 start-page: 284 year: 2010 end-page: 295 ident: bib33 article-title: A conditional maximized sequential probability ratio test for pharmacovigilance publication-title: Stat Med – volume: 263 start-page: 831 year: 1990 end-page: 839 ident: bib7 article-title: Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment publication-title: JAMA – volume: 49 start-page: 834 year: 2011 end-page: 841 ident: bib11 article-title: Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007 publication-title: Med Care – volume: 45 start-page: S89 year: 2007 end-page: S95 ident: bib34 article-title: Real-time vaccine safety surveillance for the early detection of adverse events publication-title: Med Care – year: 2002 ident: bib3 article-title: Experimental and Quasi-Experimental Designs for Generalized Causal Inference – volume: 317 start-page: 550 year: 1987 end-page: 556 ident: bib8 article-title: Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity publication-title: N Engl J Med – reference: Hilt R. Primary care principles for child mental health, version 4.0. Available at: – volume: 71 start-page: 38 year: 1981 ident: 10.1016/j.acap.2013.08.002_bib9 article-title: Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care publication-title: Am J Public Health doi: 10.2105/AJPH.71.1.38 – volume: 16 start-page: 1275 year: 2007 ident: 10.1016/j.acap.2013.08.002_bib31 article-title: Early detection of adverse drug events within population-based health networks: application of sequential testing methods publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1509 – ident: 10.1016/j.acap.2013.08.002_bib25 – volume: 15 start-page: 1 year: 2013 ident: 10.1016/j.acap.2013.08.002_bib19 article-title: Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers: is it justified? publication-title: Paediatr Drugs doi: 10.1007/s40272-012-0001-5 – volume: 45 start-page: 1284 year: 2006 ident: 10.1016/j.acap.2013.08.002_bib21 article-title: Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1097/01.chi.0000235077.32661.61 – volume: 27 start-page: 299 year: 2002 ident: 10.1016/j.acap.2013.08.002_bib4 article-title: Segmented regression analysis of interrupted time series studies in medication use research publication-title: J Clin Pharm Ther doi: 10.1046/j.1365-2710.2002.00430.x – volume: 60 start-page: 520 year: 2009 ident: 10.1016/j.acap.2013.08.002_bib14 article-title: Effects of prior authorization on medication discontinuation among Medicaid beneficiaries with bipolar disorder publication-title: Psychiatr Serv doi: 10.1176/appi.ps.60.4.520 – year: 2002 ident: 10.1016/j.acap.2013.08.002_bib3 – volume: 49 start-page: 834 year: 2011 ident: 10.1016/j.acap.2013.08.002_bib11 article-title: Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007 publication-title: Med Care doi: 10.1097/MLR.0b013e3182162afb – volume: 27 start-page: w185 year: 2008 ident: 10.1016/j.acap.2013.08.002_bib13 article-title: Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change publication-title: Health Aff (Millwood) doi: 10.1377/hlthaff.27.3.w185 – volume: 304 start-page: 2279 year: 2010 ident: 10.1016/j.acap.2013.08.002_bib5 article-title: How to use an article about quality improvement publication-title: JAMA doi: 10.1001/jama.2010.1692 – year: 1980 ident: 10.1016/j.acap.2013.08.002_bib10 – volume: 166 start-page: 651 year: 2012 ident: 10.1016/j.acap.2013.08.002_bib17 article-title: Safety effects of drawstring requirements for children’s upper outerwear garments publication-title: Arch Pediatr Adolesc Med doi: 10.1001/archpediatrics.2011.1269 – volume: 169 start-page: 750 year: 2009 ident: 10.1016/j.acap.2013.08.002_bib12 article-title: Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees publication-title: Arch Intern Med doi: 10.1001/archinternmed.2009.39 – volume: 45 start-page: S89 issue: 10 suppl 2 year: 2007 ident: 10.1016/j.acap.2013.08.002_bib34 article-title: Real-time vaccine safety surveillance for the early detection of adverse events publication-title: Med Care doi: 10.1097/MLR.0b013e3180616c0a – volume: 63 start-page: 256 year: 2012 ident: 10.1016/j.acap.2013.08.002_bib29 article-title: Impact of electronic health record transition on behavioral health screening in a large pediatric practice publication-title: Psychiatr Serv doi: 10.1176/appi.ps.201100207 – volume: 1 start-page: 31 year: 2000 ident: 10.1016/j.acap.2013.08.002_bib2 article-title: The value of interrupted time-series experiments for community intervention research publication-title: Prev Sci doi: 10.1023/A:1010024016308 – ident: 10.1016/j.acap.2013.08.002_bib27 – ident: 10.1016/j.acap.2013.08.002_bib26 – volume: 317 start-page: 550 year: 1987 ident: 10.1016/j.acap.2013.08.002_bib8 article-title: Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity publication-title: N Engl J Med doi: 10.1056/NEJM198708273170906 – volume: 48 start-page: 740 year: 2009 ident: 10.1016/j.acap.2013.08.002_bib23 article-title: Second opinions improve ADHD prescribing in a Medicaid-insured community population publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1097/CHI.0b013e3181a2b2ed – volume: 50 start-page: 987 year: 2012 ident: 10.1016/j.acap.2013.08.002_bib16 article-title: Atomoxetine use during a period of FDA actions publication-title: Med Care doi: 10.1097/MLR.0b013e31826c86f1 – volume: 13 start-page: 563 year: 2010 ident: 10.1016/j.acap.2013.08.002_bib20 article-title: Pediatricians’ attitudes and practices on ADHD before and after the development of ADHD pediatric practice guidelines publication-title: J Atten Disord doi: 10.1177/1087054709344194 – volume: 62 start-page: 143 year: 2009 ident: 10.1016/j.acap.2013.08.002_bib30 article-title: Methods for estimating confidence intervals in interrupted time series analyses of health interventions publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2008.08.007 – volume: 29 start-page: 284 year: 2010 ident: 10.1016/j.acap.2013.08.002_bib33 article-title: A conditional maximized sequential probability ratio test for pharmacovigilance publication-title: Stat Med doi: 10.1002/sim.3780 – volume: 21 start-page: 209 year: 1997 ident: 10.1016/j.acap.2013.08.002_bib1 article-title: Analysis approaches to community evaluation publication-title: Eval Rev doi: 10.1177/0193841X9702100205 – volume: 331 start-page: 650 year: 1994 ident: 10.1016/j.acap.2013.08.002_bib6 article-title: Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia publication-title: N Engl J Med doi: 10.1056/NEJM199409083311006 – volume: 128 start-page: 2011 year: 2011 ident: 10.1016/j.acap.2013.08.002_bib18 article-title: ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents publication-title: Pediatrics – volume: 325 start-page: 1072 year: 1991 ident: 10.1016/j.acap.2013.08.002_bib15 article-title: Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes publication-title: N Engl J Med doi: 10.1056/NEJM199110103251505 – volume: 263 start-page: 831 year: 1990 ident: 10.1016/j.acap.2013.08.002_bib7 article-title: Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment publication-title: JAMA doi: 10.1001/jama.1990.03440060077036 – volume: 167 start-page: 162 year: 2013 ident: 10.1016/j.acap.2013.08.002_bib22 article-title: The Partnership Access Line: evaluating a child psychiatry consult program in Washington State publication-title: JAMA Pediatr doi: 10.1001/2013.jamapediatrics.47 – volume: 21 start-page: 72 issue: suppl 1 year: 2012 ident: 10.1016/j.acap.2013.08.002_bib32 article-title: Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini-Sentinel pilot publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.2320 – ident: 10.1016/j.acap.2013.08.002_bib24 – ident: 10.1016/j.acap.2013.08.002_bib28 |
| SSID | ssj0063886 |
| Score | 2.571076 |
| SecondaryResourceType | review_article |
| Snippet | Interrupted time series (ITS) analysis is arguably the strongest quasi-experimental research design. ITS is particularly useful when a randomized trial is... Abstract Interrupted time series (ITS) analysis is arguably the strongest quasi-experimental research design. ITS is particularly useful when a randomized... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | S38 |
| SubjectTerms | Antipsychotic Agents - therapeutic use Attention Deficit Disorder with Hyperactivity - diagnosis Attention Deficit Disorder with Hyperactivity - drug therapy Child, Preschool Delivery of Health Care - standards Delivery of Health Care - trends Female Health Services Research Humans interrupted time series Interrupted Time Series Analysis Male Neonatal and Perinatal Medicine Pediatrics Pediatrics - standards Pediatrics - trends Quality Assurance, Health Care Quality Improvement quasi-experimental research design United States |
| Title | Use of Interrupted Time Series Analysis in Evaluating Health Care Quality Improvements |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1876285913002106 https://www.clinicalkey.es/playcontent/1-s2.0-S1876285913002106 https://dx.doi.org/10.1016/j.acap.2013.08.002 https://www.ncbi.nlm.nih.gov/pubmed/24268083 https://www.proquest.com/docview/1465859186 |
| Volume | 13 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFA6iIL6Id-dlRPBN6tpcTPcoY2Mq7kUnvoU0S2Qi3Vi3B1_87eY0aUF0Cj625NImJydfkvN9Qeg8scCPVCJyUD6NmFU8yohWkRKGWzeDCZoAwfl-cNUfsttn_ryCOhUXBsIqg-_3Pr301uFNK7Rmazoetx4SGMggv0bLhQvIbjMmwMovP-owD2de5W2PkDiC1IE442O8lFagWZnQSx9SuWxyWgY-y0mot4U2A3rE1_4Dt9GKyXfQ-n04H99FT8PC4InF5T7fbDF1cBIDyQPDJpgpcCVBgsc57gad7_wFey4SBi4S9qIa79jvNpSbh8UeGva6j51-FG5OiDQn6TxKdHZls7hNRzZ2naQyrtjIQUOriIiF5sYwOqJKuV4aWVhhacWJ0hbCDDkjhu6j1XySm0OE26AIaAVxBbkymG0blmTKoRCjSWqoaKCkajKpg6w43G7xJqv4sVcJzSyhmSVceRmTBrqo80y9qMavqWnVE7KiizoHJ53P_zWX-CmXKcIYLWQiCyJj-c2OGojXOb-Y4p81nlVmIt0YhYMXlZvJooDlFYcKUlf2gbef-r8BIqUOBx_9s9ZjtAFPnh55glbns4U5dThpnjXLgdBEa9c3d_3BJ6VjED8 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCb6ANpdinZtt6wvDdhtcGNLVuwchyBFujW9rBl6E2RFKlIMThAnh17620dacoBifQC92nrYEkl9kviRAN8SR_xInUUI5fModVpGBTc60pmVDlewTCREcB5edwaj9OetvF2DXsOFIbfKYPu9Ta-tdXjSDqPZnk0m7d8JKTKFXxP1xqWzDpspqi-lMTh_XPl5oHzV6R6pdETFA3PGO3lpoyloZSLOvU_lS6vTS-izXoUudmEnwEf2w3_hHqzZ8iNsDcMF-T78GVWWTR2rD_rmyxniSUYsD0anYLZiTQwSNilZPwT6Lu-YJyMxIiMxH1Xjgfnjhvr0sDqA0UX_pjeIQuqEyEieL6LEFB1XxF0xdjHOki6kTseIDZ3mWZwZaW0qxkJrnKaxoy2W0ZJr48jPUKbcikPYKKel_QysSyEBXcaxIWwjdV2bJoVGGGINz63IWpA0Q6ZMiCtO6S3-qsaB7F7RMCsaZkU5L2Pegu-rOjMfVePV0qKZCdXwRdHCKTT6r9bKnqtlq6CklUpUxVWs_hOkFshVzSey-GaPXxsxUaikdPOiSztdVrS_ktRBjm1_8vKz-m_CSDkC4S_v7PUMtgc3wyt1dXn96wg-0BvPlTyGjcV8aU8QNC2K01op_gG7dxHN |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+interrupted+time+series+analysis+in+evaluating+health+care+quality+improvements&rft.jtitle=Academic+pediatrics&rft.au=Penfold%2C+Robert+B&rft.au=Zhang%2C+Fang&rft.date=2013-11-01&rft.issn=1876-2867&rft.eissn=1876-2867&rft.volume=13&rft.issue=6+Suppl&rft.spage=S38&rft_id=info:doi/10.1016%2Fj.acap.2013.08.002&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F18762859%2FS1876285913X00075%2Fcov150h.gif |